| Literature DB >> 9428765 |
A Hemminki1, D Markie, I Tomlinson, E Avizienyte, S Roth, A Loukola, G Bignell, W Warren, M Aminoff, P Höglund, H Järvinen, P Kristo, K Pelin, M Ridanpää, R Salovaara, T Toro, W Bodmer, S Olschwang, A S Olsen, M R Stratton, A de la Chapelle, L A Aaltonen.
Abstract
Studies of hereditary cancer syndromes have contributed greatly to our understanding of molecular events involved in tumorigenesis. Here we investigate the molecular background of the Peutz-Jeghers syndrome (PJS), a rare hereditary disease in which there is predisposition to benign and malignant tumours of many organ systems. A locus for this condition was recently assigned to chromosome 19p. We have identified truncating germline mutations in a gene residing on chromosome 19p in multiple individuals affected by PJS. This previously identified but unmapped gene, LKB1, has strong homology to a cytoplasmic Xenopus serine/threonine protein kinase XEEK1, and weaker similarity to many other protein kinases. Peutz-Jeghers syndrome is therefore the first cancer-susceptibility syndrome to be identified that is due to inactivating mutations in a protein kinase.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9428765 DOI: 10.1038/34432
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962